Shiverer*jimpy double mutant mice. I. Biochemical evidence for reciprocal intergenic suppression

Shiverer and jimpy are neurological mutations that cause hypomyelination in the mouse CNS. The 3 major protein components of CNS myelin are: myelin basic protein (MBP), proteolipid (PLP) and 2', 3'-cyclic nucleotide phosphohydrolase (CNP). Previous work has shown that in jimpy animals the CNS contains reduced levels of MBP and CNP while PLP is undetectable. In shiverer animals the major forms of MBP ae undetectable in either the CNS or PNS, but the level of CNP is unaffected by mutation. In this study we have measured MBP, PLP and CNP in both the CNS (cerebral hemispheres) and PNS (sciatic nerve) of mice carrying the jimpy and shiverer mutations, individually and in combination. The results indicate that in the double mutant the levels of all 3 myelin proteins in both the CNS and PNS are intermediate between the levels in jimpy and the levels in shiverer animals. This means that part of the biochemical phenotype of the jimpy mutation (reduced levels of CNP and absence of PLP) is suppressed by the shiverer mutation, and part of the biochemical phenotype of the shiverer mutation (absence of MBP) is suppressed by the jimpy mutation. Possible mechanisms for this reciprocal intergenic suppression are discussed.     

Myelination and glial ensheathment of purkinje cells in cerebellar cultures are not inhibited by antibodies to the neural cell adhesion molecule, N-CAM

Mouse cerebellar cultures were exposed to anti-N-CAM antibodies throughout their in vitro development. Some cultures were stripped of myelinating oligodendrocytes and functionally competent astrocytes by treatment with cytosine arabinoside (Ara C), while others were left untreated and were potentially capable of forming myelin around axons and astrocytic sheaths around Purkinje cell somata and dendrites. As expected, the antibodies inhibited axonal fasciculation in the Ara C treated cultures. However, the same antibodies had no discernible effect on formation of myelin or astrocytic sheaths in cultures not treated with Ara C. N-CAM is expressed on the surfaces of neurons, oligodendroglia and astrocytes, and has been proposed as the signal molecule governing both kinds of neuron-glia interactions. The observations of the present study strongly suggest, however, that N-CAM does not have an indispensable role in such interactions.     

Synaptic Development and Related Disturbances*

Abstract Characteristics of synaptic development are as follows: 1) an increase-decrease in the number of synapses consisting of an over-production followed by elimination, the end product being the maturing form; 2) with maturation, there is a transformation from the axo-dendritic shaft synapses to the axo-dendritic spine ones. In early development, synaptogenesis probably proceeds simultaneously with myelination. A suggestion that the critical period giving definitive impairments in the organization of synapses exists may be raised. Quantitative analyses of the mitochondrial number in. the presynapse, determined using conventional osmium tetroxide staining and the number of synaptic junction determined using the EPTA preferential procedure reveal the synaptic changes, both in normal development or in response to nutritional and pharmacological factors.     

Systematic and differential myelination of axon collaterals in the mammalian auditory brainstem

A brainstem circuit for encoding the spatial location of sounds involves neurons in the cochlear nucleus that project to medial superior olivary (MSO) neurons on both sides of the brain via a single bifurcating axon. Neurons in MSO act as coincidence detectors, responding optimally when signals from the two ears arrive within a few microseconds. To achieve this, transmission of signals along the contralateral collateral must be faster than transmission of the same signals along the ipsilateral collateral. We demonstrate that this is achieved by differential regulation of myelination and axon caliber along the ipsilateral and contralateral branches of single axons; ipsilateral axon branches have shorter internode lengths and smaller caliber than contralateral branches. The myelination difference is established prior to the onset of hearing. We conclude that this differential myelination and axon caliber requires local interactions between axon collaterals and surrounding oligodendrocytes on the two sides of the brainstem. GLIA 2016;64:487–494     

Gelsolin is required for macrophage recruitment during remyelination of the peripheral nervous system

Reorganization of the actin cytoskeleton is necessary for Schwann cell proliferation, migration and for the morphological changes associated with sorting, ensheathing and myelination of axons. Such reorganization requires regulated severing and depolymerization of actin filaments. Gelsolin is an actin filament severing protein expressed in many cell types including Schwann cells. Using Gelsolin knockout mice, we investigated the role of this protein in the myelination and remyelination of the peripheral nervous system. Our results show that although gelsolin is not necessary for developmental myelination, it is required for timely remyelination of the sciatic nerve following crush injury. Gelsolin is necessary for macrophage motility in culture, and its absence is likely to impair the recruitment of macrophages to the injury site. © 2009 Wiley‐Liss, Inc.     

不同发育阶段大鼠脑髓鞘化的研究

目的 研究大鼠不同发育阶段脑髓鞘化的发展及规律.方法 应用LFB髓鞘染色、MBP免疫组化及Wes-tern blot观察不同发育阶段大鼠脑髓鞘的分布及变化.结果 LFB及MBP免疫组化染色E18、P0、P2均未见着色,P7大鼠胼胝体中部少量LFB着色,P15两种染色均呈阳性,P30着色加深,与P90、P720类似.通过Western blot检测MBP蛋白在孕中后期已有表达,出生后随日龄增长逐渐增加,至老年期表达量最高.结论 大鼠脑髓鞘化从P15已经开始,P30接近成熟;观察髓鞘的最佳时间在30 d以后.     

Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice

Our groups have reported that tumor necrosis factor-alpha (TNF-alpha) causes myelin damage and apoptosis of oligodendrocytes and their precursors in vitro and in vivo. We also have reported that insulin-like growth factor-I (IGF-I) can protect cultured oligodendrocytes and their precursors from TNF-alpha-induced damage. In this study, we investigated whether IGF-I can protect oligodendrocytes and myelination from TNF-alpha-induced damage in vivo by cross-breeding TNF-alpha transgenic (Tg) mice with IGF-I Tg mice that overexpress IGF-I exclusively in brain. At 8 weeks of age, compared with those of wild-type (WT) mice, the brain weights of TNF-alpha Tg mice were decreased by approximately 20%, and those of IGF-I Tg mice were increased by approximately 20%. The brain weights of mice that carry both TNF-alpha and IGF-I transgenes (TNF-alpha/IGF-I Tg mice) did not differ from those of WT mice. As judged by histochemical staining and immunostaining, myelin content in the cerebellum of TNF-alpha/IGF-I Tg mice was similar to that in WT mice and much more than that in TNF-alpha Tg mice. Consistently, Western immunoblot analysis showed that myelin basic protein (MBP) abundance in the cerebellum of TNF-alpha/IGF-I Tg mice was double that in TNF-alpha Tg mice. In comparison with WT mice, the number of oligodendrocytes was decreased by approximately 36% in TNF-alpha Tg mice, whereas it was increased in IGF-I Tg mice by approximately 40%. Oligodendrocyte number in TNF-alpha/IGF-I Tg mice was almost twice that in TNF-alpha Tg mice. Furthermore, IGF-I overexpression significantly reduced TNF-alpha-induced increases in apoptotic cell number, active caspase-3 abundance, and degradaion of MBP. Our results indicate that IGF-I is capable of protecting myelin and oligodendrocytes from TNF-alpha-induced damage in vivo.     

NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells

Cellular specification of the oligodendrocyte lineage occurs through a series of stages identified by expression of distinct biochemical characteristics. The best characterized oligodendrocyte progenitor cell (OPC) in vitro is the bipotential O2-A progenitor, identified by labeling with monoclonal antibody A2B5, which proliferates predominantly in response to platelet derived growth factor (PDGF). The cellular ancestors of O2-A progenitor cells are currently unclear. In vivo OPCs can be identified by expression of the cell surface markers NG2 (a sulfated proteoglycan) and platelet derived growth factor receptor alphaR). Substantial evidence supports the generation of oligodendrocytes from NG2(+), PDGFalphaR(+) cells both in vivo and in vitro. The developmental relationship between NG2(+) cells and A2B5(-) positive cells is unknown and it is unclear whether they represent identical, partially overlapping or nonoverlapping populations of cells. Here we show that in cultures of developing brain NG2(+) and A2B5(+) cells arise from overlapping cell populations. NG2(+) cells appear prior to the expression of A2B5(+) cells and generate A2B5(+) cells. We propose that during development NG2(+)/A2B5(-) cells (pre-OPCs) represent the direct ancestor to A2B5(+) O2A progenitor cells (OPCs).     

GDNF‐enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons

We previously demonstrated that coadministration of glial cell line‐derived neurotrophic factor (GDNF) with grafts of Schwann cells (SCs) enhanced axonal regeneration and remyelination following spinal cord injury (SCI). However, the cellular target through which GDNF mediates such actions was unclear. Here, we report that GDNF enhanced both the number and caliber of regenerated axons in vivo and increased neurite outgrowth of dorsal root ganglion neurons (DRGN) in vitro, suggesting that GDNF has a direct effect on neurons. In SC‐DRGN coculture, GDNF significantly increased the number of myelin sheaths produced by SCs. GDNF treatment had no effect on the proliferation of isolated SCs but enhanced the proliferation of SCs already in contact with axons. GDNF increased the expression of the 140 kDa neural cell adhesion molecule (NCAM) in isolated SCs but not their expression of the adhesion molecule L1 or the secretion of the neurotrophins NGF, NT3, or BDNF. Overall, these results support the hypothesis that GDNF‐enhanced axonal regeneration and SC myelination is mediated mainly through a direct effect of GDNF on neurons. They also suggest that the combination of GDNF administration and SC transplantation may represent an effective strategy to promote axonal regeneration and myelin formation after injury in the spinal cord. © 2009 Wiley‐Liss, Inc.